Moneycontrol
HomeNewsBusinessIn COVID-19, Harsh Mariwala gets an unlikely enabler to scale his Ascent initiative
Trending Topics

In COVID-19, Harsh Mariwala gets an unlikely enabler to scale his Ascent initiative

After the pandemic struck, Ascent went virtual. It has never expanded in its eight years, as it did in the last six months.

November 18, 2020 / 15:51 IST
Story continues below Advertisement

Bhagirath Jalan had wanted to join Ascent Foundation in 2016. But then, the platform created by Marico founder Harsh Mariwala to help entrepreneurs learn from each other’s experience, only had chapters in Mumbai and Chennai.

"I couldn't travel to Mumbai once a month, as was mandated," says Jalan, who runs his family's Dindayal Jalan Retails Private Limited from Varanasi. Members of Ascent Foundation are divided into various groups and meet every month to discuss, debate and share experience on varied issues concerning business.

Story continues below Advertisement

The wish however remained. The Foundation, which had started in 2012, was highly recommended to Jalan by SC Mishra, a retail industry veteran who had worked closely with some of the sector stalwarts, including Kishore Biyani. In fact, Jalan had worked in the Future Group in Mumbai, after doing his MBA from Cardiff University. A year later he went back to Varanasi to join the family business that is among the biggest retailers in Uttar Pradesh.

"It is difficult to openly discuss about your business with others here in Varanasi," said Jalan.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show